Mon, 11 Nov 2019 12:00:00 EST Control:Diabetes Pilot Study I Conditions: Insulin Treated Type 2 Diabetes Mellitus; Diabetes Mellitus, Type 1 Intervention: Other: Control:Diabetes mobile app Sponsor: Brigham and Women's Hospital Recruiting
Mon, 11 Nov 2019 12:00:00 EST Mindfulness IN-home for Diabetes and Sleep Health Conditions: Diabetes; Diabetes Mellitus, Type 2 Intervention: Behavioral: Mindfulness-based stress reduction (MBSR) Intervention Sponsors: Emory University; Georgia Center for Diabetes Translation Research; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Recruiting
Fri, 08 Nov 2019 12:00:00 EST Context Aware Data Gathering Study Condition: Type 1 Diabetes Intervention: Other: Exercise Sponsors: Oregon Health and Science University; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Not yet recruiting
Thu, 07 Nov 2019 12:00:00 EST Mediterranean Diet Versus Exercise to Lower Cardiometabolic Risk Conditions: Overweight or Obesity; Visceral Steatosis Intervention: Other: energy deficit Sponsors: Oslo University Hospital; The National Association for Public Health, Norway Not yet recruiting
Thu, 07 Nov 2019 12:00:00 EST Osmotic Agent Use in Middle Cerebral Artery Stroke Conditions: Ischemic Stroke; MCA Infarction Intervention: Other: No intervention is planned, this will be a purely retrospective trial. Sponsor: University of Minnesota Completed
Thu, 07 Nov 2019 12:00:00 EST Pharmacokinetics, Safety and Tolerability of CKD-387 10/500mg BE Phase1 Condition: Type2 Diabetes Mellitus Interventions: Drug: Part A, Reference (D635 10/500mg, Astrazeneca); Drug: Part B, Reference (D635 10/500mg, Astrazeneca) Sponsor: Chong Kun Dang Pharmaceutical Completed
FDA (Food and Drug Administration) press releases. FDA makes sure of the safety of all medicines which can be injected, breathed in, rubbed in and swallowed, in the United States of America.
